TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Cancer Gene Therapy Market
Cancer Gene Therapy Market, Global Outlook and Forecast 2023-2030

Cancer Gene Therapy Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 25 December 2022
  • Pages :89
  • Formats:
  • Report Code:SMR-7520056
OfferClick for best price

Best Price: $2320

Cancer Gene Therapy Market Size, Share 2022


Market Analysis and Insights: Global Cancer Gene Therapy Market

The global Cancer Gene Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Gene Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Gene Therapy market.

Global Cancer Gene Therapy Scope and Market Size

Cancer Gene Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.

Segment by Type

Oncolytic Virotherapy

Gene Transfer

Gene-Induced Immunotherapy

Segment by Application

Hospitals

Diagnostics Centers

Research Institutes

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Adaptimmune

Bluebird bio

Celgene

Shanghai Sunway Biotech

Shenzhen SiBiono GeneTech

SynerGene Therapeutics

Altor BioScience

Amgen

Argenx

BioCancell

GlaxoSmithKline

Merck

OncoGenex Pharmaceuticals

Transgene

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Cancer Gene Therapy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Cancer Gene Therapy, with price, sales, revenue, and global market share of Cancer Gene Therapy from 2019 to 2022.

Chapter 3, the Cancer Gene Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Cancer Gene Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Cancer Gene Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Gene Therapy.

Chapter 13, 14, and 15, to describe Cancer Gene Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Cancer Gene Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Cancer Gene Therapy Market, Global Outlook and Forecast 2023-2030
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 89 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2018-2030)
2.2 Cancer Gene Therapy Growth Trends by Region
2.2.1 Cancer Gene Therapy Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Cancer Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2023-2030)
2.3 Cancer Gene Therapy Market Dynamics
2.3.1 Cancer Gene Therapy Industry Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Revenue
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2022
3.5 Cancer Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Gene Therapy Product Solution and Service
3.7 Date of Enter into Cancer Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2030)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2018-2030)
6.2 North America Cancer Gene Therapy Market Size by Country (2018-2023)
6.3 North America Cancer Gene Therapy Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2018-2030)
7.2 Europe Cancer Gene Therapy Market Size by Country (2018-2023)
7.3 Europe Cancer Gene Therapy Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Therapy Market Size (2018-2030)
8.2 Asia-Pacific Cancer Gene Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Gene Therapy Market Size (2018-2030)
9.2 Latin America Cancer Gene Therapy Market Size by Country (2018-2023)
9.3 Latin America Cancer Gene Therapy Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Therapy Market Size (2018-2030)
10.2 Middle East & Africa Cancer Gene Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Detail
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023)
11.2.5 Bluebird bio Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Detail
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023)
11.4.5 Shanghai Sunway Biotech Recent Development
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Detail
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023)
11.5.5 Shenzhen SiBiono GeneTech Recent Development
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Detail
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023)
11.6.5 SynerGene Therapeutics Recent Development
11.7 Altor BioScience
11.7.1 Altor BioScience Company Detail
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023)
11.7.5 Altor BioScience Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2018-2023)
11.8.5 Amgen Recent Development
11.9 Argenx
11.9.1 Argenx Company Detail
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2018-2023)
11.9.5 Argenx Recent Development
11.10 BioCancell
11.10.1 BioCancell Company Detail
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2018-2023)
11.10.5 BioCancell Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2018-2023)
11.12.5 Merck Recent Development
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Detail
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023)
11.13.5 OncoGenex Pharmaceuticals Recent Development
11.14 Transgene
11.14.1 Transgene Company Detail
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.14.5 Transgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Cancer Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 7. Global Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Region (2018-2023)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Region (2023-2030)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cancer Gene Therapy Market Share by Players (2018-2023)
Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Gene Therapy Product Solution and Service
Table 22. Date of Enter into Cancer Gene Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2023-2030)
Table 28. Global Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2023-2030)
Table 32. North America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Country (2023-2030) & (US$ Million)
Table 34. Europe Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Cancer Gene Therapy Market Size by Country (2023-2030) & (US$ Million)
Table 36. Asia-Pacific Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Cancer Gene Therapy Market Size by Region (2023-2030) & (US$ Million)
Table 38. Latin America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Cancer Gene Therapy Market Size by Country (2023-2030) & (US$ Million)
Table 40. Middle East & Africa Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2030) & (US$ Million)
Table 42. Adaptimmune Company Detail
Table 43. Adaptimmune Business Overview
Table 44. Adaptimmune Cancer Gene Therapy Product
Table 45. Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 46. Adaptimmune Recent Development
Table 47. Bluebird bio Company Detail
Table 48. Bluebird bio Business Overview
Table 49. Bluebird bio Cancer Gene Therapy Product
Table 50. Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 51. Bluebird bio Recent Development
Table 52. Celgene Company Detail
Table 53. Celgene Business Overview
Table 54. Celgene Cancer Gene Therapy Product
Table 55. Celgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 56. Celgene Recent Development
Table 57. Shanghai Sunway Biotech Company Detail
Table 58. Shanghai Sunway Biotech Business Overview
Table 59. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 60. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 61. Shanghai Sunway Biotech Recent Development
Table 62. Shenzhen SiBiono GeneTech Company Detail
Table 63. Shenzhen SiBiono GeneTech Business Overview
Table 64. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 65. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 66. Shenzhen SiBiono GeneTech Recent Development
Table 67. SynerGene Therapeutics Company Detail
Table 68. SynerGene Therapeutics Business Overview
Table 69. SynerGene Therapeutics Cancer Gene Therapy Product
Table 70. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 71. SynerGene Therapeutics Recent Development
Table 72. Altor BioScience Company Detail
Table 73. Altor BioScience Business Overview
Table 74. Altor BioScience Cancer Gene Therapy Product
Table 75. Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 76. Altor BioScience Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Cancer Gene Therapy Product
Table 80. Amgen Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Argenx Company Detail
Table 83. Argenx Business Overview
Table 84. Argenx Cancer Gene Therapy Product
Table 85. Argenx Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 86. Argenx Recent Development
Table 87. BioCancell Company Detail
Table 88. BioCancell Business Overview
Table 89. BioCancell Cancer Gene Therapy Product
Table 90. BioCancell Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 91. BioCancell Recent Development
Table 92. GlaxoSmithKline Company Detail
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Cancer Gene TherapyProduct
Table 95. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Cancer Gene TherapyProduct
Table 100. Merck Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Development
Table 102. OncoGenex Pharmaceuticals Company Detail
Table 103. OncoGenex Pharmaceuticals Business Overview
Table 104. OncoGenex Pharmaceuticals Cancer Gene TherapyProduct
Table 105. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 106. OncoGenex Pharmaceuticals Recent Development
Table 107. Transgene Company Detail
Table 108. Transgene Business Overview
Table 109. Transgene Cancer Gene TherapyProduct
Table 110. Transgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 111. Transgene Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Gene Therapy Market Share by Type: 2022 VS 2030
Figure 2. Oncolytic Virotherapy Features
Figure 3. Gene Transfer Features
Figure 4. Gene-Induced Immunotherapy Features
Figure 5. Global Cancer Gene Therapy Market Share by Application in 2022 & 2030
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Cancer Gene Therapy Report Years Considered
Figure 10. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 11. Global Cancer Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 12. Global Cancer Gene Therapy Market Share by Region: 2022 VS 2030
Figure 13. Global Cancer Gene Therapy Market Share by Players in 2022
Figure 14. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2022
Figure 16. North America Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 17. North America Cancer Gene Therapy Market Share by Country (2018-2030)
Figure 18. United States Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 19. Canada Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 20. Europe Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 21. Europe Cancer Gene Therapy Market Share by Country (2018-2030)
Figure 22. Germany Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. France Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. U.K. Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Italy Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Russia Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Asia-Pacific Cancer Gene Therapy Market Share by Region (2018-2030)
Figure 30. China Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Japan Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. South Korea Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. India Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Australia Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Latin America Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Latin America Cancer Gene Therapy Market Share by Country (2018-2030)
Figure 38. Mexico Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Brazil Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Middle East & Africa Cancer Gene Therapy Market Share by Country (2018-2030)
Figure 42. Turkey Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 45. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 46. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 47. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 48. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 49. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 50. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 51. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 52. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 53. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 56. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 57. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount